SubHero Banner
Text

2nd Quarter 2021

Key topics in this quarter’s edition include:

  • Teplizumab for the delay of type 1 diabetes mellitus
  • Finerenone for treatment of chronic kidney disease in type 2 diabetes mellitus patients
  • Atogepant for migraine prophylaxis

Download PDF

Text